Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study

• Status: Completed
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this feasibility study is to identify appropriate surrogate parameters for a randomized study to examine the efficacy of a complementary therapy with an extract of viscum album (Iscador P) in patients with breast cancer.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Heidelberg University
• Collaborators: Verein für Krebsforschung, Arlesheim, Swizzerland; Weleda AG, D-73525 Schwäbisch Gmünd
• Treatments: Viscum album peptide

Criteria

Inclusion Criteria:

• breast cancer

• desire for additional therapy with mistletoe extracts

Exclusion Criteria:

• contraindication for a therapy with mistletoe extracts(allergy, tuberculosis, hyperthyreosis, acute infectious disease, intracranial pressure in case of tumors or metastasis)

• current medication with glucocorticoids or other immunosuppressive therapies

• other concomitant complementary therapies

• prior therapy with mistletoe extracts > 2 years or during the last 6 months

• karnofsky-Index <60